Literature DB >> 30656621

Chemically Defined Neural Conversion of Human Pluripotent Stem Cells.

Yu Chen1, Carlos A Tristan1, Sunil K Mallanna1, Pinar Ormanoglu1, Steven Titus1, Anton Simeonov1, Ilyas Singeç2.   

Abstract

Human pluripotent stem cells (hPSCs) are characterized by their ability to self-renew and differentiate into any cell type of the human body. To fully utilize the potential of hPSCs for translational research and clinical applications, it is critical to develop rigorous cell differentiation protocols under feeder-free conditions that are efficient, reproducible, and scalable for high-throughput projects. Focusing on neural conversion of hPSCs, here we describe robust small molecule-based procedures that generate neural stem cells (NSCs) in less than a week under chemically defined conditions. These protocols can be used to dissect the mechanisms of neural lineage entry and to further develop systematic protocols that produce the cellular diversity of the central nervous system at industrial scale.

Entities:  

Keywords:  Cell differentiation; Coating substrate; Culture medium; Embryonic stem cell; Induced pluripotent stem cell; Neural induction; Pathway inhibition; Pluripotency; Small molecules

Mesh:

Substances:

Year:  2019        PMID: 30656621      PMCID: PMC6908303          DOI: 10.1007/978-1-4939-9007-8_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  26 in total

1.  Feeder-independent culture of human embryonic stem cells.

Authors:  Tenneille E Ludwig; Veit Bergendahl; Mark E Levenstein; Junying Yu; Mitchell D Probasco; James A Thomson
Journal:  Nat Methods       Date:  2006-08       Impact factor: 28.547

2.  Defined human pluripotent stem cell culture enables highly efficient neuroepithelium derivation without small molecule inhibitors.

Authors:  Ethan Scott Lippmann; Maria Carolina Estevez-Silva; Randolph Scott Ashton
Journal:  Stem Cells       Date:  2014-04       Impact factor: 6.277

3.  Neural progenitors from human embryonic stem cells.

Authors:  B E Reubinoff; P Itsykson; T Turetsky; M F Pera; E Reinhartz; A Itzik; T Ben-Hur
Journal:  Nat Biotechnol       Date:  2001-12       Impact factor: 54.908

4.  Specification of motoneurons from human embryonic stem cells.

Authors:  Xue-Jun Li; Zhong-Wei Du; Ewa D Zarnowska; Matthew Pankratz; Lauren O Hansen; Robert A Pearce; Su-Chun Zhang
Journal:  Nat Biotechnol       Date:  2005-01-30       Impact factor: 54.908

5.  Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions.

Authors:  Jeanette Beers; Daniel R Gulbranson; Nicole George; Lauren I Siniscalchi; Jeffrey Jones; James A Thomson; Guokai Chen
Journal:  Nat Protoc       Date:  2012-10-25       Impact factor: 13.491

6.  Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm.

Authors:  Joseph R Smith; Ludovic Vallier; Giuseppe Lupo; Morgan Alexander; William A Harris; Roger A Pedersen
Journal:  Dev Biol       Date:  2007-10-11       Impact factor: 3.582

7.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

8.  Higher-Density Culture in Human Embryonic Stem Cells Results in DNA Damage and Genome Instability.

Authors:  Kurt Jacobs; Filippo Zambelli; Afroditi Mertzanidou; Ilse Smolders; Mieke Geens; Ha Thi Nguyen; Lise Barbé; Karen Sermon; Claudia Spits
Journal:  Stem Cell Reports       Date:  2016-02-25       Impact factor: 7.765

9.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

10.  Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells.

Authors:  Ludovic Vallier; Morgan Alexander; Roger A Pedersen
Journal:  J Cell Sci       Date:  2005-10-01       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.